These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 17156136)

  • 1. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.
    Matsuoka K; Iwao Y; Mori T; Sakuraba A; Yajima T; Hisamatsu T; Okamoto S; Morohoshi Y; Izumiya M; Ichikawa H; Sato T; Inoue N; Ogata H; Hibi T
    Am J Gastroenterol; 2007 Feb; 102(2):331-7. PubMed ID: 17156136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.
    Roblin X; Pillet S; Oussalah A; Berthelot P; Del Tedesco E; Phelip JM; Chambonnière ML; Garraud O; Peyrin-Biroulet L; Pozzetto B
    Am J Gastroenterol; 2011 Nov; 106(11):2001-8. PubMed ID: 21788989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus.
    Fukuchi T; Nakase H; Matsuura M; Yoshino T; Toyonaga T; Ohmori K; Ubukata S; Ueda A; Eguchi T; Yamashita H; Ito D; Ashida K
    J Crohns Colitis; 2013 Nov; 7(10):803-11. PubMed ID: 23352104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
    Clos-Parals A; Rodríguez-Martínez P; Cañete F; Mañosa M; Ruiz-Cerulla A; José Paúles M; Llaó J; Gordillo J; Fumagalli C; Garcia-Planella E; Ojanguren I; Cabré E; Guardiola J; Domènech E
    J Crohns Colitis; 2019 Mar; 13(3):385-388. PubMed ID: 30346606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hazardous burden of Herpesviridae in inflammatory bowel disease: the case of refractory severe ulcerative colitis.
    Lavagna A; Bergallo M; Daperno M; Sostegni R; Ravarino N; Crocellà L; Ramella A; Rocca R; Torchio B; Cavallo R; Pera A
    Dig Liver Dis; 2006 Dec; 38(12):887-93. PubMed ID: 16931197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection.
    Maconi G; Colombo E; Zerbi P; Sampietro GM; Fociani P; Bosani M; Cassinotti A; Casini V; Russo A; Ardizzone S; Porta M; Bianchi Porro G
    Dig Liver Dis; 2005 Jun; 37(6):418-23. PubMed ID: 15893280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus Infection in Ulcerative Colitis is Related to Severe Inflammation and a High Count of Cytomegalovirus-positive Cells in Biopsy Is a Risk Factor for Colectomy.
    Zagórowicz E; Bugajski M; Wieszczy P; Pietrzak A; Magdziak A; Mróz A
    J Crohns Colitis; 2016 Oct; 10(10):1205-11. PubMed ID: 26971053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection in patients with new onset ulcerative colitis: a prospective study.
    Kim YS; Kim YH; Kim JS; Cheon JH; Ye BD; Jung SA; Park YS; Choi CH; Jang BI; Han DS; Yang SK; Kim WH;
    Hepatogastroenterology; 2012 Jun; 59(116):1098-101. PubMed ID: 22580660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus.
    Iida T; Ikeya K; Watanabe F; Abe J; Maruyama Y; Ohata A; Teruyuki S; Sugimoto K; Hanai H
    Inflamm Bowel Dis; 2013 May; 19(6):1156-63. PubMed ID: 23619714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease.
    Sipponen T; Turunen U; Lautenschlager I; Nieminen U; Arola J; Halme L
    Scand J Gastroenterol; 2011 Nov; 46(11):1324-33. PubMed ID: 21879802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases.
    Lévêque N; Brixi-Benmansour H; Reig T; Renois F; Talmud D; Brodard V; Coste JF; De Champs C; Andréoletti L; Diebold MD
    J Med Virol; 2010 Oct; 82(10):1694-700. PubMed ID: 20827767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient.
    Pfau P; Kochman ML; Furth EE; Lichtenstein GR
    Am J Gastroenterol; 2001 Mar; 96(3):895-9. PubMed ID: 11280572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients.
    Kamar N; Mengelle C; Esposito L; Guitard J; Mehrenberger M; Lavayssière L; Ribes D; Cointault O; Durand D; Izopet J; Rostaing L
    J Med Virol; 2008 Jun; 80(6):1012-7. PubMed ID: 18428146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies.
    Yoshino T; Nakase H; Ueno S; Uza N; Inoue S; Mikami S; Matsuura M; Ohmori K; Sakurai T; Nagayama S; Hasegawa S; Sakai Y; Chiba T
    Inflamm Bowel Dis; 2007 Dec; 13(12):1516-21. PubMed ID: 17828781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.
    Pillet S; Jarlot C; Courault M; Del Tedesco E; Chardon R; Saint-Sardos P; Presles E; Phelip JM; Berthelot P; Pozzetto B; Roblin X
    Inflamm Bowel Dis; 2015 Jul; 21(7):1580-6. PubMed ID: 25933392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment.
    Wada Y; Matsui T; Matake H; Sakurai T; Yamamoto J; Kikuchi Y; Yorioka M; Tsuda S; Yao T; Yao S; Haraoka S; Iwashita A
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S59-65. PubMed ID: 14530660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis.
    Kim JW; Boo SJ; Ye BD; Kim CL; Yang SK; Kim J; Kim SA; Park SH; Park SK; Yang DH; Jung KW; Kim KJ; Byeon JS; Myung SJ; Kim JH
    J Crohns Colitis; 2014 Jul; 8(7):693-701. PubMed ID: 24405983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study.
    Kim YS; Kim YH; Kim JS; Jeong SY; Park SJ; Cheon JH; Ye BD; Jung SA; Park YS; Choi CH; Kim KO; Jang BI; Han DS; Yang SK; Kim WH
    Gut Liver; 2014 Nov; 8(6):643-7. PubMed ID: 25368753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.